Autoimmunity and Turner's syndrome

Autoimmunity Reviews

Volumn 11, Issue 6-7, 2012, Pages

  Lleo, Ana ^a,b   Moroni, Luca ^a   Caliari, Lisa ^a,b   Invernizzi, Pietro ^a,c  

^a HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Autoimmunity; Genetic factors; HLA; Turner Syndrome; X chromosome

Indexed keywords

HLA ANTIGEN;

ALOPECIA AREATA; AUTOIMMUNITY; CELIAC DISEASE; CROHN DISEASE; DUPUYTREN CONTRACTURE; HALO NEVUS; HASHIMOTO DISEASE; HUMAN; IMMUNOPATHOGENESIS; INSULIN DEPENDENT DIABETES MELLITUS; JUVENILE RHEUMATOID ARTHRITIS; MAJOR HISTOCOMPATIBILITY COMPLEX; PSORIASIS; REVIEW; TURNER SYNDROME; ULCERATIVE COLITIS; VITILIGO; X CHROMOSOME;

AUTOANTIBODIES; AUTOIMMUNE DISEASES; AUTOIMMUNITY; CHROMOSOMES, HUMAN, X; CHROMOSOMES, HUMAN, Y; FEMALE; HUMANS; IMMUNOLOGIC FACTORS; MAJOR HISTOCOMPATIBILITY COMPLEX; TURNER SYNDROME;

EID: 84858451819     PISSN: 15689972     EISSN: 18730183     Source Type: Journal    
DOI: 10.1016/j.autrev.2011.11.015     Document Type: Review

References (90)

1. Menasha J., Levy B., Hirschhorn K., Kardon N.B. Incidence and spectrum of chromosome abnormalities in spontaneous abortions: new insights from a 12-year study. Genet Med 2005, 7:251-263.
2. Zenaty D., Laurent M., Carel J.C., Leger J. Turner Syndrome: What's new in medical care?. Arch Pediatr 2011, 18:1338-1342.
3. Gravholt C.H. Epidemiological, endocrine and metabolic features in Turner Syndrome. Eur J Endocrinol 2004, 151:657-687.
4. Persani L., Rossetti R., Cacciatore C., Bonomi M. Primary Ovarian Insufficiency: X chromosome defects and autoimmunity. J Autoimmun 2009, 33:35-41.
5. Ford C.E., Jones K.W., Polani P.E., De Almeida J.C., Briggs J.H. A sex-chromosome anomaly in a case of gonadal dysgenesis (Turner's syndrome]. Lancet 1959, 1:711-713.
6. Fraccaro M., Kaijser K., Lindsten J. Further cytogenetical observations in gonadal dysgenesis. Ann Hum Genet 1960, 24:205-211.
7. Carrel L., Cottle A.A., Goglin K.C., Willard H.F. A first-generation X-inactivation profile of the human X chromosome. Proc Natl Acad Sci U S A 1999, 96:14440-14444.
8. Avner P., Heard E. X-chromosome inactivation: counting, choice and initiation. Nat Rev Genet 2001, 2:59-67.
9. Zinn A.R., Ross J.L. Turner Syndrome and haploinsufficiency. Curr Opin Genet Dev 1998, 8:322-327.
10. Mortensen K.H., Cleemann L., Hjerrild B.E., Nexo E., Locht H., Jeppesen E.M., et al. Increased prevalence of autoimmunity in Turner Syndrome-influence of age. Clin Exp Immunol 2009, 156:205-210.
11. Stenberg A.E., Sylven L., Magnusson C.G., Hultcrantz M. Immunological parameters in girls with Turner Syndrome. J Negat Results Biomed 2004, 3:6.
12. Mackay I.R., Leskovsek N.V., Rose N.R. The odd couple: a fresh look at autoimmunity and immunodeficiency. J Autoimmun 2010, 35:199-205.
13. Lowenstein E.J., Kim K.H., Glick S.A. Turner's syndrome in dermatology. J Am Acad Dermatol 2004, 50:767-776.
14. Livadas S., Xekouki P., Fouka F., Kanaka-Gantenbein C., Kaloumenou I., Mavrou A., et al. Prevalence of thyroid dysfunction in Turner's syndrome: a long-term follow-up study and brief literature review. Thyroid 2005, 15:1061-1066.
15. El-Mansoury M., Bryman I., Berntorp K., Hanson C., Wilhelmsen L., Landin-Wilhelmsen K. Hypothyroidism is common in Turner Syndrome: results of a five-year follow-up. J Clin Endocrinol Metab 2005, 90:2131-2135.
16. Hayward P.A., Satsangi J., Jewell D.P. Inflammatory bowel disease and the X chromosome. QJM 1996, 89:713-718.
17. Wihlborg C.E., Babyn P.S., Schneider R. The association between Turner's syndrome and juvenile rheumatoid arthritis. Pediatr Radiol 1999, 29:676-681.
18. Durusu M., Gurlek A., Simsek H., Balaban Y., Tatar G. Coincidence or causality: celiac and Crohn diseases in a case of Turner Syndrome. Am J Med Sci 2005, 329:214-216.
19. Ivarsson S.A., Ericsson U.B., Nilsson K.O., Gustafsson J., Hagenas L., Hager A., et al. Thyroid autoantibodies, Turner's syndrome and growth hormone therapy. Acta Paediatr 1995, 84:63-65.
20. Oiso N., Ota T., Kawara S., Kawada A. Pustular psoriasis and vitiligo in a patient with Turner Syndrome. J Dermatol 2007, 34:727-729.
21. Price W.H. A high incidence of chronic inflammatory bowel disease in patients with Turner's syndrome. J Med Genet 1979, 16:263-266.
22. Germain E.L., Plotnick L.P. Age-related anti-thyroid antibodies and thyroid abnormalities in Turner Syndrome. Acta Paediatr Scand 1986, 75:750-755.
23. Jorgensen K.T., Rostgaard K., Bache I., Biggar R.J., Nielsen N.M., Tommerup N., et al. Autoimmune diseases in women with Turner's syndrome. Arthritis Rheum 2010, 62:658-666.
24. Arslan D., Kuyucu T., Kendirci M., Kurtoglu S. Celiac disease and Turner's syndrome: patient report. J Pediatr Endocrinol Metab 2000, 13:1629-1631.
25. Rujner J., Wisniewski A., Gregorek H., Wozniewicz B., Mlynarski W., Witas H.W. Coeliac disease and HLA-DQ 2 (DQA1* 0501 and DQB1* 0201) in patients with Turner Syndrome. J Pediatr Gastroenterol Nutr 2001, 32:114-115.
26. Scarpa R., Lubrano E., Castiglione F., Morace F., Ames P.R., Oriente P. Juvenile rheumatoid arthritis, Crohn's disease and Turner's syndrome: a novel association. Clin Exp Rheumatol 1996, 14:449-450.
27. Irvine W.J., Chan M.M., Scarth L., Kolb F.O., Hartog M., Bayliss R.I., et al. Immunological aspects of premature ovarian failure associated with idiopathic Addison's disease. Lancet 1968, 2:883-887.
28. Rosina P., Segalla G., Magnanini M., Chieregato C., Barba A. Turner's syndrome associated with psoriasis and alopecia areata. J Eur Acad Dermatol Venereol 2003, 17:50-52.
29. Blaschke R.J., Rappold G. The pseudoautosomal regions, SHOX and disease. Curr Opin Genet Dev 2006, 16:233-239.
30. Helena Mangs A., Morris B.J. The Human Pseudoautosomal Region (PAR): Origin, Function and Future. Curr Genomics 2007, 8:129-136.
31. Sagi L., Zuckerman-Levin N., Gawlik A., Ghizzoni L., Buyukgebiz A., Rakover Y., et al. Clinical significance of the parental origin of the X chromosome in Turner Syndrome. J Clin Endocrinol Metab 2007, 92:846-852.
32. Uematsu A., Yorifuji T., Muroi J., Kawai M., Mamada M., Kaji M., et al. Parental origin of normal X chromosomes in Turner Syndrome patients with various karyotypes: implications for the mechanism leading to generation of a 45, X karyotype. Am J Med Genet 2002, 111:134-139.
33. Thompson N.P., Montgomery S.M., Wadsworth M.E., Pounder R.E., Wakefield A.J. Early determinants of inflammatory bowel disease: use of two national longitudinal birth cohorts. Eur J Gastroenterol Hepatol 2000, 12:25-30.
34. Gravholt C.H., Juul S., Naeraa R.W., Hansen J. Morbidity in Turner Syndrome. J Clin Epidemiol 1998, 51:147-158.
35. Larizza D., Calcaterra V., Martinetti M. Autoimmune stigmata in Turner Syndrome: when lacks an X chromosome. J Autoimmun 2009, 33:25-30.
36. Radetti G., Mazzanti L., Paganini C., Bernasconi S., Russo G., Rigon F., et al. Frequency, clinical and laboratory features of thyroiditis in girls with Turner's syndrome. The Italian Study Group for Turner's Syndrome. Acta Paediatr 1995, 84:909-912.
37. Chiovato L., Larizza D., Bendinelli G., Tonacchera M., Marino M., Mammoli C., et al. Autoimmune hypothyroidism and hyperthyroidism in patients with Turner's syndrome. Eur J Endocrinol 1996, 134:568-575.
38. Elsheikh M., Wass J.A., Conway G.S. Autoimmune thyroid syndrome in women with Turner's syndrome-the association with karyotype. Clin Endocrinol (Oxf) 2001, 55:223-226.
39. Elsheikh M., Dunger D.B., Conway G.S., Wass J.A. Turner's syndrome in adulthood. Endocr Rev 2002, 23:120-140.
40. Nienhuis H.E., Rongen-Westerlaken C., Geertzen H.G., Rijkers G.T., Zegers B.J., Wit J.M. Long-term effect of human growth hormone therapy on the prevalence of autoantibodies in Turner syndrome. The Dutch Growth Hormone Working Group. Horm Res 1993, 39(Suppl. 2):49-53.
41. Marcocci C., Bartalena L., Martino E., Fenzi G.F., Pinchera A. Graves' disease and Turner's syndrome. J Endocrinol Invest 1980, 3:429-431.
42. Rose N.R. The genetics of autoimmune thyroiditis: the first decade. J Autoimmun 2011, 37:88-94.
43. Sparkes R.S., Motulsky A.G. Hashimoto's disease in Turner's Syndrome with isochromosome X. Lancet 1963, 1:947.
44. Gonc E.N., Ozon A., Alikasifoglu A., Kandemir N. Type 1 diabetes mellitus in a 3 1/2 year-old girl with Turner's Syndrome. J Pediatr Endocrinol Metab 2002, 15:1203-1206.
45. Cassidy S.B., Niblack G.D., Lorber C.A., Mann J.M., Engel E. HLA frequencies, diabetes mellitus and autoimmunity in Turner's patients and their relatives. Ann Genet 1978, 21:203-208.
46. Rolandsson O., Hagg E., Hampe C., Sullivan E.P., Nilsson M., Jansson G., et al. Glutamate decarboxylase (GAD65) and tyrosine phosphatase-like protein (IA-2) autoantibodies index in a regional population is related to glucose intolerance and body mass index. Diabetologia 1999, 42:555-559.
47. Hasham A., Tomer Y. The recent rise in the frequency of type 1 diabetes: who pulled the trigger?. J Autoimmun 2011, 37:1-2.
48. Ziegler A.G., Pflueger M., Winkler C., Achenbach P., Akolkar B., Krischer J.P., et al. Accelerated progression from islet autoimmunity to diabetes is causing the escalating incidence of type 1 diabetes in young children. J Autoimmun 2011, 37:3-7.
49. Tobon G.J., Pers J.O., Canas C.A., Rojas-Villarraga A., Youinou P., Anaya J.M. Are autoimmune diseases predictable?. Autoimmun Rev 2012, 11:259-266.
50. Bonamico M., Pasquino A.M., Mariani P., Danesi H.M., Culasso F., Mazzanti L., et al. Prevalence and clinical picture of celiac disease in Turner Syndrome. J Clin Endocrinol Metab 2002, 87:5495-5498.
51. Watabe H., Kawakami T., Kimura S., Fujimoto M., Ono T., Mizoguchi M., et al. Childhood psoriasis associated with Turner Syndrome. J Dermatol 2006, 33:896-898.
52. Tebbe B., Gollnick H., Muller R., Reupke H.J., Orfanos C.E. Alopecia areata and diffuse hypotrichosis associated with Ullrich-Turner Syndrome. Presentation of 4 patients. Hautarzt 1993, 44:647-652.
53. de Andrade M., Jackow C.M., Dahm N., Hordinsky M., Reveille J.D., Duvic M. Alopecia areata in families: association with the HLA locus. J Investig Dermatol Symp Proc 1999, 4:220-223.
54. Brazzelli V., Larizza D., Martinetti M., Martinoli S., Calcaterra V., De Silvestri A., et al. Halo nevus, rather than vitiligo, is a typical dermatologic finding of Turner's syndrome: clinical, genetic, and immunogenetic study in 72 patients. J Am Acad Dermatol 2004, 51:354-358.
55. Zulian F., Schumacher H.R., Calore A., Goldsmith D.P., Athreya B.H. Juvenile arthritis in Turner's syndrome: a multicenter study. Clin Exp Rheumatol 1998, 16:489-494.
56. Sokol L., Stueben E.T., Jaikishen J.P., Lamarche M.B. Turner Syndrome associated with acquired von Willebrand disease, primary biliary cirrhosis, and inflammatory bowel disease. Am J Hematol 2002, 70:257-259.
57. Larizza D., Martinetti Bianchi M., Lorini R., Maghnie M., Dugoujon J.M., Cuccia Belvedere M., et al. Autoimmunity, HLA, Gm and Km polymorphisms in Turner's Syndrome. Autoimmunity 1989, 4:69-78.
58. Gluck M., Attanasio A., Speer U., Butenandt O., Tietze H.U., Scherbaum W.A. Prevalence of autoantibodies to endocrine organs in girls with Ullrich-Turner Syndrome aged 5-14years. Horm Res 1992, 38:114-119.
59. Larizza D., Martinetti M., Lorini R., Dugoujon J.M., Tinelli C., Vitali L., et al. Parental segregation of autoimmunity in patients with Turner's syndrome: preferential paternal transmission?. J Autoimmun 1999, 12:65-72.
60. Sybert V.P., McCauley E. Turner's syndrome. N Engl J Med 2004, 351:1227-1238.
61. Fonager K., Sorensen H.T., Rasmussen S.N., Moller-Petersen J., Vyberg M. Assessment of the diagnoses of Crohn's disease and ulcerative colitis in a Danish hospital information system. Scand J Gastroenterol 1996, 31:154-159.
62. Pedersen M., Klarlund M., Jacobsen S., Svendsen A.J., Frisch M. Validity of rheumatoid arthritis diagnoses in the Danish National Patient Registry. Eur J Epidemiol 2004, 19:1097-1103.
63. Fialkow P.J. Autoimmunity and chromosomal aberrations. Am J Hum Genet 1966, 18:93-108.
64. Vallotton M.B., Forbes A.P. Autoimmunity in gonadal dysgenesis and Klinefelter's syndrome. Lancet 1967, 1:648-651.
65. O.L. Quintero, M.J. Amador-Patarroyo, G. Montoya-Ortiz, A. Rojas-Villarraga, J.M. Anaya, Autoimmune disease and gender: Plausible mechanisms for the female predominance of autoimmunity. J Autoimmun in press. [Electronic publication ahead of print].
66. Klein L., Klugmann M., Nave K.A., Tuohy V.K., Kyewski B. Shaping of the autoreactive T-cell repertoire by a splice variant of self protein expressed in thymic epithelial cells. Nat Med 2000, 6:56-61.
67. Invernizzi P. Future directions in genetic for autoimmune diseases. J Autoimmun 2009, 33:1-2.
68. Invernizzi P., Gershwin M.E. The genetics of human autoimmune disease. J Autoimmun 2009, 33:290-299.
69. Invernizzi P., Pasini S., Selmi C., Gershwin M.E., Podda M. Female predominance and X chromosome defects in autoimmune diseases. J Autoimmun 2009, 33:12-16.
70. Chitnis S., Monteiro J., Glass D., Apatoff B., Salmon J., Concannon P., et al. The role of X-chromosome inactivation in female predisposition to autoimmunity. Arthritis Res 2000, 2:399-406.
71. Jensen K., Petersen P.H., Nielsen E.L., Dahl G., Nielsen J. Serum immunoglobulin M, G, and A concentration levels in Turner's syndrome compared with normal women and men. Hum Genet 1976, 31:329-334.
72. Rongen-Westerlaken C., Rijkers G.T., Scholtens E.J., van Es A., Wit J.M., van den Brande J.L., et al. Immunologic studies in Turner Syndrome before and during treatment with growth hormone. The Dutch Growth Hormone Working Group. J Pediatr 1991, 119:268-272.
73. Lorini R., Ugazio A.G., Cammareri V., Larizza D., Castellazzi A.M., Brugo M.A., et al. Immunoglobulin levels, T-cell markers, mitogen responsiveness and thymic hormone activity in Turner's syndrome. Thymus 1983, 5:61-66.
74. Lessard C.J., Ice J.A., Adrianto I., Wiley G.B., Kelly J.A., Gaffney P.M., et al. The genomics of autoimmune disease in the era of genome-wide association studies and beyond. Autoimmun Rev 2012, 11:267-275.
75. Horton R., Wilming L., Rand V., Lovering R.C., Bruford E.A., Khodiyar V.K., et al. Gene map of the extended human MHC. Nat Rev Genet 2004, 5:889-899.
76. Larizza D., Cuccia M., Martinetti M., Maghnie M., Dondi E., Salvaneschi L., et al. Adrenocorticotrophin stimulation and HLA polymorphisms suggest a high frequency of heterozygosity for steroid 21-hydroxylase deficiency in patients with Turner's syndrome and their families. Clin Endocrinol (Oxf) 1994, 40:39-45.
77. Larizza D., Calcaterra V., Martinetti M., Negrini R., De Silvestri A., Cisternino M., et al. Helicobacter pylori infection and autoimmune thyroid disease in young patients: the disadvantage of carrying the human leukocyte antigen-DRB1*0301 allele. J Clin Endocrinol Metab 2006, 91:176-179.
78. Kong Y.C., Brown N.K., Flynn J.C., McCormick D.J., Brusic V., Morris G.P., et al. Efficacy of HLA-DRB1 *03:01 and H2E transgenic mouse strains to correlate pathogenic thyroglobulin epitopes for autoimmune thyroiditis. J Autoimmun 2011, 37:63-70.
79. Larizza D., Martinetti M., Pizzochero C., Cuccia M., Severi F. Influence of HLA genotype on birth weight of patients with Turner Syndrome. Hum Genet 1992, 88:383-387.
80. Larizza D., Martinetti M., Dugoujon J.M., Tinelli C., Calcaterra V., Cuccia M., et al. Parental GM and HLA genotypes and reduced birth weight in patients with Turner's syndrome. J Pediatr Endocrinol Metab 2002, 15:1183-1190.
81. N. Gleicher, A. Weghofer, D.H. Barad, 2011. Cutting edge assessment of the impact of autoimmunity on female reproductive success. J Autoimmun in press. [Electronic publication ahead of print].
82. Galarza-Maldonado C., Kourilovitch M.R., Perez-Fernandez O.M., Gaybor M., Cordero C., Cabrera S., et al. Obstetric antiphospholipid syndrome. Autoimmun Rev 2012, 11:288-295.
83. Sierra S., Stephenson M. Genetics of recurrent pregnancy loss. Semin Reprod Med 2006, 24:17-24.
84. Sukhikh G.T., Nurutdinova R.A., Murashko L.E., Faizullin L.Z. Effect of HLA-compatibility in married couples on the development and severity of gestosis. Bull Exp Biol Med 2007, 143:222-224.
85. Varla-Leftherioti M., Keramitsoglou T., Spyropoulou-Vlachou M., Papadimitropoulos M., Kontopoulou-Antonopoulou V., Tsekoura C., et al. 14th International HLA and Immunogenetics Workshop: report from the reproductive immunology component. Tissue Antigens 2007, 69(Suppl. 1):297-303.
86. Cuccia M., Martinetti M., Larizza D., Bolis P.F., Severi F. Excess of HLA parental sharing in families with Turner patients. Clin Genet 1990, 38:415-421.
87. Martinetti M., Degioanni A., D'Aronzo A.M., Benazzi E., Carpanelli R., Castellani L., et al. An immunogenetic map of Lombardy (Northern Italy). Ann Hum Genet 2002, 66:37-48.
88. Aroviita P., Partanen J., Sistonen P., Teramo K., Kekomaki R. High birth weight is associated with human leukocyte antigen (HLA) DRB1*13 in full-term infants. Eur J Immunogenet 2004, 31:21-26.
89. Mantovani V., Dondi E., Larizza D., Cisternino M., Bragliani M., Viggiani M., et al. Do reduced levels of steroid 21-hydroxylase confer a survival advantage in fetuses affected by sex chromosome aberrations?. Eur J Hum Genet 2002, 10:137-140.
90. Barabas A.Z., Cole C.D., Graeff R.M., Lafreniere R., Weir D.M. The role of autoimmunologists in investigating and treating autoimmune disorders. Autoimmun Rev 2011, 10:166-170.